Discontinuation report NORMOSOL-R
Report ID | 205624 |
Drug Identification Number | 00039500 |
Brand name | NORMOSOL-R |
Common or Proper name | Multiple Electrolytes Injection Type 1 USP pH 7.4 |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM GLUCONATE SODIUM ACETATE SODIUM CHLORIDE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE |
Strength(s) | 0.502G 0.222G 0.526G 0.014G 0.037G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000 mL |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-05-31 |
Actual discontinuation date | 2024-07-19 |
Remaining supply date | 2023-12-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Last lot expires 31-MAY-2024 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-07-20 | English | Compare |
v9 | 2024-07-19 | French | Compare |
v8 | 2024-07-19 | French | Compare |
v7 | 2024-07-19 | English | Compare |
v6 | 2023-10-27 | French | Compare |
v5 | 2023-10-27 | English | Compare |
v4 | 2023-10-02 | French | Compare |
v3 | 2023-10-02 | English | Compare |
v2 | 2023-10-02 | French | Compare |
v1 | 2023-10-02 | English | Compare |
Showing 1 to 10 of 10